BAP1 and lung cancer: A significantly higher proportion of high-penetrance PGVs predisposing patients to lung cancers, including TP53, EGFR, and BAP1, have been detected in patients who had multiple primary tumors, family history of any cancer, or early age of diagnosis compared to noncarriers [29].